Taichu Biotechnology Funding: $57M Raised, Series A (2023)
Taichu Biotechnology has raised $57M in total funding. Latest round: Series A. Backed by IDG Capital, Shanghai Healthcare Capital, Yijing Capital.
Taichu Biotechnology funding overview
Taichu Biotechnology has raised $57M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in May 2023. The round record for Taichu Biotechnology runs through 2023; nothing later has been disclosed. Investors on record include IDG Capital, Shanghai Healthcare Capital, Yijing Capital. 3 distinct backers are named across the disclosed rounds.
Taichu Biotechnology at a glance
Total raised
$57M
Latest round
Series A
Latest round date
May 2023
Notable investors
IDG Capital, Shanghai Healthcare Capital, Yijing Capital
Frequently asked about Taichu Biotechnology funding
How much has Taichu Biotechnology raised?
Taichu Biotechnology has raised $57M in total disclosed funding across the rounds on record.
Who has invested in Taichu Biotechnology?
IDG Capital, Shanghai Healthcare Capital, Yijing Capital are named among the investors backing Taichu Biotechnology.
What was the latest Taichu Biotechnology funding round?
The most recent disclosed round is a Series A, announced in May 2023.
Where is Taichu Biotechnology based?
No headquarters location is disclosed for Taichu Biotechnology.
When did Taichu Biotechnology last raise?
The last disclosed Taichu Biotechnology round closed in May 2023 at Series A.
Round data for Taichu Biotechnology is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies and backer lists below.
